145 related articles for article (PubMed ID: 32756110)
1. Sero-survey of polio antibodies and quality of acute flaccid paralysis surveillance in Chongqing, China: A cross-sectional study.
Xu J; Kuang S; Rong R; Zhang Y; Tang W; Wang Q
Medicine (Baltimore); 2020 Jul; 99(31):e21298. PubMed ID: 32756110
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological serosurvey of poliovirus in Guangdong, China: A cross-sectional study.
Tan Q; Zhu Q; Zheng H; Zhang B; Wu C; Guo X; Li H; Liu L; Liu Y; Rutherford S; Zheng H
Hum Vaccin Immunother; 2018; 14(11):2644-2648. PubMed ID: 30059644
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of sequential poliovirus vaccination schedules with different strains of poliomyelitis vaccines in Chongqing, China: a cross-sectional survey.
Xu J; Wang Q; Kuang S; Rong R; Zhang Y; Fu X; Tang W
Hum Vaccin Immunother; 2021 Jul; 17(7):2125-2131. PubMed ID: 33759702
[TBL] [Abstract][Full Text] [Related]
4. Immunity status against poliomyelitis in young migrants: a seroprevalence study.
Veronesi L; Colucci ME; Capobianco E; Bracchi MT; Zoni R; Palandri L; Affanni P
Acta Biomed; 2019 Sep; 90(9-S):28-34. PubMed ID: 31517887
[TBL] [Abstract][Full Text] [Related]
5. Population immunity to polioviruses in the context of a large-scale wild poliovirus type 1 outbreak in Tajikistan, 2010.
Khetsuriani N; Pallansch MA; Jabirov S; Saparova N; Oberste MS; Wannemuehler K; Ursu P; Wassilak S; Martin R
Vaccine; 2013 Oct; 31(42):4911-6. PubMed ID: 23891502
[TBL] [Abstract][Full Text] [Related]
6. Lower immunity to poliomyelitis viruses in Australian young adults not eligible for inactivated polio vaccine.
Hendry AJ; Beard FH; Dey A; Quinn H; Hueston L; Dwyer DE; McIntyre PB
Vaccine; 2020 Mar; 38(11):2572-2577. PubMed ID: 32037225
[TBL] [Abstract][Full Text] [Related]
7. A national cross-sectional study for poliovirus seroprevalence in the Republic of Korea in 2012: implication for deficiency in immunity to polio among middle-aged people.
Kim HJ; Hwang S; Lee S; Kwon Y; Park K; Park YJ; Bae GR; Lee SW; Jeong YS; Hyeon JY
BMC Infect Dis; 2015 Mar; 15():164. PubMed ID: 25881203
[TBL] [Abstract][Full Text] [Related]
8. Poliovirus neutralizing antibody levels among individuals in three regions of Ghana.
Opare JK; Akweongo P; Afari EA; Odoom JK
Ghana Med J; 2019 Jun; 53(2):170-180. PubMed ID: 31481814
[TBL] [Abstract][Full Text] [Related]
9. A study evaluating poliovirus antibodies and risk factors associated with polio seropositivity in low socioeconomic areas of Pakistan.
Habib M; Soofi S; Ali N; Sutter RW; Palansch M; Qureshi H; Akhtar T; Molodecky NA; Okayasu H; Bhutta ZA
Vaccine; 2013 Apr; 31(15):1987-93. PubMed ID: 23429005
[TBL] [Abstract][Full Text] [Related]
10. Poliovirus immunity among pregnant females aged 15-44 years, Namibia, 2010.
Cardemil CV; Jonas A; Gerber S; Weldon WC; Oberste MS; Beukes A; Sawadogo S; Patel SV; Zeko S; Muroua C; Gaeb E; Wannemuehler K; Goodson JL
J Infect Dis; 2014 Nov; 210 Suppl 1(Suppl 1):S136-42. PubMed ID: 25316828
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of anti-polio antibodies in children from polio high risk area of Afghanistan: A cross sectional survey 2017.
Hussain I; Mach O; Hamid NA; Bhatti ZS; Moore DD; Oberste MS; Khan S; Khan H; Weldon WC; Sutter RW; Bhutta ZA; Soofi SB
Vaccine; 2018 Apr; 36(15):1921-1924. PubMed ID: 29510918
[TBL] [Abstract][Full Text] [Related]
12. Assessment of seroprevalence against poliovirus among Italian adolescents and adults.
Lupi S; Stefanati A; Baldovin T; Roman A; Baldo V; Gabutti G
Hum Vaccin Immunother; 2019; 15(3):677-682. PubMed ID: 30427738
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of poliovirus antibodies in Nigeria: refining strategies to sustain the eradication effort.
Bolu O; Adamu U; Franka R; Umeokonkwo CD; An Q; Greby S; McDonald S; Mainou B; Mba N; Agala N; Archer WR; Braka F; Etapelong SG; Gashu TS; Siddique AR; Asekun A; Okoye M; Iriemenam N; Wiesen E; Swaminathan M; Ihekweazu C; Shuaib F
Pan Afr Med J; 2023; 45(Suppl 2):2. PubMed ID: 38370104
[TBL] [Abstract][Full Text] [Related]
14. Assessment of poliovirus antibody seroprevalence in polio high risk areas of West Africa.
Guindo O; Mach O; Doumbia S; Ekra DK; Beavogui AH; Weldon WC; Oberste MS; Sutter RW
Vaccine; 2018 Feb; 36(8):1027-1031. PubMed ID: 29358054
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of immunity to poliovirus type 3: a lurking danger?
Reinheimer C; Friedrichs I; Rabenau HF; Doerr HW
BMC Infect Dis; 2012 Jan; 12():24. PubMed ID: 22280025
[TBL] [Abstract][Full Text] [Related]
16. Serological investigation on the prevalence of poliovirus in Guangdong province: A cross-sectional study.
Chen L; Qiu Q; Zhu Q; Li J; Xie X; Shao X; Liang J; Zhang W; Zheng H; Li B; Xu L; Zeng H; Sun L
Hum Vaccin Immunother; 2024 Dec; 20(1):2300156. PubMed ID: 38189143
[TBL] [Abstract][Full Text] [Related]
17. An epidemiological analysis of Acute Flaccid Paralysis (AFP) surveillance in Kenya, 2016 to 2018.
Tesfaye B; Sowe A; Kisangau N; Ogange J; Ntoburi S; Nekar I; Muitherero C; Camara Y; Gathenji C; Langat D; Sergon K; Limo H; Nzunza R; Kiptoon S; Kareko D; Onuekwusi I
BMC Infect Dis; 2020 Aug; 20(1):611. PubMed ID: 32811467
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of Anti-polio Antibodies in Children From Polio High-risk Areas of Pakistan: A Cross-Sectional Survey 2015-2016.
Hussain I; Mach O; Habib A; Bhatti Z; Suhag Z; Oberste MS; Weldon WC; Sutter RW; Soofi SB; Bhutta ZA
Pediatr Infect Dis J; 2017 Sep; 36(9):e230-e236. PubMed ID: 28806355
[TBL] [Abstract][Full Text] [Related]
19. Poliovirus Type 2 Seroprevalence Following Full- or Fractional-Dose Inactivated Poliovirus Vaccine in the Period After Sabin Type 2 Withdrawal in Sri Lanka.
Gamage D; Mach O; Ginige S; Weldon WC; Oberste MS; Jeyaseelan V; Sutter RW
J Infect Dis; 2019 May; 219(12):1887-1892. PubMed ID: 30649505
[TBL] [Abstract][Full Text] [Related]
20. Vaccine-associated paralytic poliomyelitis and other diseases with acute flaccid paralysis syndrome in Belarus.
Samoilovich EO; Feldman EV; Yermalovich MA; Protas II; Titov LP
Cent Eur J Public Health; 2003 Dec; 11(4):213-8. PubMed ID: 14768785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
